Suryoday SFB IPO elicits mixed reaction from analysts; here’s why

The three-day initial public offer (IPO) by Suryoday (SFB) is slated to open on Wednesday, March 17 along with the much-awaited issue by Rakesh Jhunjhunwala-backed

The is a mix of an offer for sale (OFS) and a fresh issue in which the company is looking to sell 1.9 crore shares, priced in the range of Rs 303-305 per share to raise up to Rs 581 crore. Investors can bid for a minimum of 49 shares and in multiples thereof. The bank proposes to utilise the net proceeds from the fresh issue towards augmenting its Tier – 1 capital base and to meet future capital requirements.

Analysts covering the share mixed views and are split between high valuations and good return ratios.

“The is valued at 2.7x of 9MFY20 book value, which appears to be at a premium of 30-35 per cent compared to Ujjivan SFB and Equitas SFB and significant discount compared to AU SFB. As AU SBF has got a significant scale with a sharp reduction in the unsecured lending book, valuation comparison with AU SFB will not be appropriate,” said Vikas Jain, senior research analyst at Reliance Securities.

But he did note that the company’s performance has been quite impressive, supported by a substantial reduction in the cost of funds and a stellar increase in advances.

The gross loan portfolio has grown at a CAGR of 47 per cent from Rs 1,718 crore in FY18 to Rs 3,711 crore as of FY20. The figure stood at Rs 3,901 crore as of Q3FY21. PAT (profit after tax) has increased at 212 per cent CAGR from Rs 11.4 crore in FY18 to Rs 111.1 crore FY20 and was at Rs 54.8 crore in 9MFY21. During FY19-FY20, its average NIM (net interest margin) came in at 12 per cent and RoE (return on equity) at 12 per cent.

However, during 9MFY21, the bank’s performance has deteriorated as pandemic led lockdown and economic crises impacted the weaker section of society severely.

“What concerns us is that with proforma GNPA (gross net performing assets) at 9.3 per cent, SSFB’s pool of bad loans is the highest among listed peers. While the collection efficiency improved to above 100 per cent (inclusive finance at 112.5 per cent in December), re-surge of Covid cases in key business states such as Maharashtra and Karnataka to weigh on revival and further weaken assets quality,” said Choice Broking in a note.

Grey market performance

As per grey market watch Manan Doshi, co-founder, the issue was commanding a premium of Rs 28-34 per share in the unlisted market, up 8-11 per cent over the issue price. “The issue looks moderately priced. The management quality of the company is very good and it also has good backing from institutional investors. This year has been very difficult for the financial sector, especially small finance banks due to the Covid-19 pandemic and hence one needs to be watchful for a few quarters on the recovery,” Doshi said.

Brokerage call

Choice Broking: Avoid

At a higher price band, the company is valued at P/BV of 2x post-issue BVPS which appears expensive given weak assets quality outlook, concentrated business to some states, low CASA share and small business size. Asked valuation is in line with peers Equitas and Ujjivan SFB but these banks are significantly large in size and have superior fundamentals than Suryoday SFB. Post issue, RoE is unlikely to improve to double-digit or FY20 level (RoE: 11.4 per cent in FY20) anytime soon. Further, it is well capitalized with CAR at 41.2 per cent. Despite this, the company comes with a fresh issue of Rs 248 crore. Considering all these parameters, we assign an ‘Avoid’ rating to the issue.

LKP Securities: Subscribe

At a higher price band (Rs 305), the stock is valued at 2.28(x) P/BVPS with a current book value per share of Rs 133.5. Factoring the good return ratios, FY20 ROA/ROE of 11.3 per cent/2.5 per cent, we believe that Suryoday is worth subscribing to. Thus we recommend Subscribe.

Equinomics Research: Avoid

“We are advising people to avoid the issue as the company is not from an attractive theme in the secondary market space and the valuations are also not comfortable. Although, risk-taking people can apply for listing day gains as all IPOs are roaring on listing day,” said G Chokkalingham, founder and MD at Economic Research.

ICICI Securities: Unrated

Suryoday SFB witnessed strong growth in advances along with maintaining asset quality. Unserved and underserved customers as targets offer a vast opportunity for business growth. At Rs 305, the stock is available at 2.1x Q3FY21 P/BV (post fresh issue).

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Source link